251 related articles for article (PubMed ID: 17251021)
21. Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design.
Good AC; Liu J; Hirth B; Asmussen G; Xiang Y; Biemann HP; Bishop KA; Fremgen T; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR
J Med Chem; 2012 Mar; 55(6):2641-8. PubMed ID: 22339127
[TBL] [Abstract][Full Text] [Related]
22. Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitors.
Shi Y; Sitkoff D; Zhang J; Klei HE; Kish K; Liu EC; Hartl KS; Seiler SM; Chang M; Huang C; Youssef S; Steinbacher TE; Schumacher WA; Grazier N; Pudzianowski A; Apedo A; Discenza L; Yanchunas J; Stein PD; Atwal KS
J Med Chem; 2008 Dec; 51(23):7541-51. PubMed ID: 18998662
[TBL] [Abstract][Full Text] [Related]
23. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
[TBL] [Abstract][Full Text] [Related]
24. Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.
Charrier JD; Miller A; Kay DP; Brenchley G; Twin HC; Collier PN; Ramaya S; Keily SB; Durrant SJ; Knegtel RM; Tanner AJ; Brown K; Curnock AP; Jimenez JM
J Med Chem; 2011 Apr; 54(7):2341-50. PubMed ID: 21391610
[TBL] [Abstract][Full Text] [Related]
25. Simplified staurosporine analogs as potent JAK3 inhibitors.
Yang SM; Malaviya R; Wilson LJ; Argentieri R; Chen X; Yang C; Wang B; Cavender D; Murray WV
Bioorg Med Chem Lett; 2007 Jan; 17(2):326-31. PubMed ID: 17088059
[TBL] [Abstract][Full Text] [Related]
26. Structure-based design of low-nanomolar PIM kinase inhibitors.
Ishchenko A; Zhang L; Le Brazidec JY; Fan J; Chong JH; Hingway A; Raditsis A; Singh L; Elenbaas B; Hong VS; Marcotte D; Silvian L; Enyedy I; Chao J
Bioorg Med Chem Lett; 2015 Feb; 25(3):474-80. PubMed ID: 25575657
[TBL] [Abstract][Full Text] [Related]
27. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
[TBL] [Abstract][Full Text] [Related]
28. 6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3β inhibitors.
Coffman K; Brodney M; Cook J; Lanyon L; Pandit J; Sakya S; Schachter J; Tseng-Lovering E; Wessel M
Bioorg Med Chem Lett; 2011 Mar; 21(5):1429-33. PubMed ID: 21295469
[TBL] [Abstract][Full Text] [Related]
29. Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors.
Chiba T; Ohwada J; Sakamoto H; Kobayashi T; Fukami TA; Irie M; Miura T; Ohara K; Koyano H
Bioorg Med Chem Lett; 2012 Dec; 22(24):7486-9. PubMed ID: 23122816
[TBL] [Abstract][Full Text] [Related]
30. Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily.
Schroeder GM; An Y; Cai ZW; Chen XT; Clark C; Cornelius LA; Dai J; Gullo-Brown J; Gupta A; Henley B; Hunt JT; Jeyaseelan R; Kamath A; Kim K; Lippy J; Lombardo LJ; Manne V; Oppenheimer S; Sack JS; Schmidt RJ; Shen G; Stefanski K; Tokarski JS; Trainor GL; Wautlet BS; Wei D; Williams DK; Zhang Y; Zhang Y; Fargnoli J; Borzilleri RM
J Med Chem; 2009 Mar; 52(5):1251-4. PubMed ID: 19260711
[TBL] [Abstract][Full Text] [Related]
31. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
[TBL] [Abstract][Full Text] [Related]
32. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism.
Xu Y; Nakajima Y; Ito K; Zheng H; Oyama H; Heiser U; Hoffmann T; Gärtner UT; Demuth HU; Yoshimoto T
J Mol Biol; 2008 Jan; 375(3):708-19. PubMed ID: 18042490
[TBL] [Abstract][Full Text] [Related]
33. Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.
Karis ND; Loughlin WA; Jenkins ID; Healy PC
Bioorg Med Chem; 2009 Jul; 17(13):4724-33. PubMed ID: 19443226
[TBL] [Abstract][Full Text] [Related]
34. Structure-guided discovery of cyclin-dependent kinase inhibitors.
Fischmann TO; Hruza A; Duca JS; Ramanathan L; Mayhood T; Windsor WT; Le HV; Guzi TJ; Dwyer MP; Paruch K; Doll RJ; Lees E; Parry D; Seghezzi W; Madison V
Biopolymers; 2008 May; 89(5):372-9. PubMed ID: 17937404
[TBL] [Abstract][Full Text] [Related]
35. N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR.
Deak HL; Newcomb JR; Nunes JJ; Boucher C; Cheng AC; DiMauro EF; Epstein LF; Gallant P; Hodous BL; Huang X; Lee JH; Patel VF; Schneider S; Turci SM; Zhu X
Bioorg Med Chem Lett; 2008 Feb; 18(3):1172-6. PubMed ID: 18083554
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifs.
Hanessian S; Simard D; Bayrakdarian M; Therrien E; Nilsson I; Fjellström O
Bioorg Med Chem Lett; 2008 Mar; 18(6):1972-6. PubMed ID: 18289852
[TBL] [Abstract][Full Text] [Related]
37. Targeting Pim-1 kinase for potential drug-development.
Gadewal N; Varma A
Int J Comput Biol Drug Des; 2012; 5(2):137-51. PubMed ID: 22854122
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
Golub AG; Yakovenko OY; Bdzhola VG; Sapelkin VM; Zien P; Yarmoluk SM
J Med Chem; 2006 Nov; 49(22):6443-50. PubMed ID: 17064064
[TBL] [Abstract][Full Text] [Related]
39. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors.
Moree WJ; Goldman P; Demaggio AJ; Christenson E; Herendeen D; Eksterowicz J; Kesicki EA; McElligott DL; Beaton G
Bioorg Med Chem Lett; 2008 Sep; 18(18):5126-9. PubMed ID: 18713665
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of the FEZ-1 metallo-beta-lactamase.
Liénard BM; Horsfall LE; Galleni M; Frère JM; Schofield CJ
Bioorg Med Chem Lett; 2007 Feb; 17(4):964-8. PubMed ID: 17157014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]